Clinical Trials Directory

Trials / Completed

CompletedNCT02663141

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine whether oral losartan is effective in the treatment of diabetic macular edema (DME) as an adjuvant for intravitreal bevacizumab (IVB).

Conditions

Interventions

TypeNameDescription
DRUGLosartan
DRUGIntravitreal bevacizumab
DRUGPlacebo

Timeline

Start date
2015-06-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-01-26
Last updated
2016-07-06

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02663141. Inclusion in this directory is not an endorsement.

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Trea (NCT02663141) · Clinical Trials Directory